Statin use is twice as high in patients with chronic muscle diseases as in unaffected controls, according to a report in the May issue of the Annals of the Rheumatic Diseases. Reuters Health Information
Learn about new biologic response modifiers and other immunologic therapies are currently being developed for the treatment of inflammatory joint diseases. Expert Review of Clinical Immunology
Chronic pain is a highly prevalent, costly, and often disabling disorder in later life. Can opioids provide safe relief? Journal of the American Geriatrics Society
This unusual case illustrates the potential for lyme disease to produce clinical syndromes indistinguishable from those of primary connective tissue diseases. Journal of Medical Case Reports
Taking into account infliximab serum levels when making dose-adjustments could lead to better disease control, new research hints. Nature Reviews Rheumatology
